G. F. Breen / Tetrahedron: Asymmetry 15 (2004) 1427–1430
1429
showed some activity. Several other commercially
available Candida rugosa lipases were then reacted with
the (R)-enantiomer to leave (S)-2 with >99% ee and
good recovery.26 One enzyme, Subtilisin protease,
showed some selectivity for the (S)-enantiomer under
these conditions to give (R)-2.
NaOH (10 mL), then dried over MgSO4 and evapo-
rated to give the crude carbonate as an oil (88–97%).
The oils were purified by distillation under reduced
pressure.
4.4. Enzyme resolution using 18
1-MTQ (5 g, 34 mmol) and 3-methoxyphenyl allylcar-
bonate (4.65 g, 22.3 mmol) were stirred in toluene
(50 mL) containing 0.05% w/w water. This can be con-
veniently achieved by stirring toluene and excess water
together then separating off the water to leave a water–
saturated toluene layer. ChiroCLEC-CR (100 mg) was
added and the reaction stirred at 30 ꢁC with the flask
connected in a closed system to another flask containing
a saturated sodium chloride solution at 50 ꢁC. The
reaction was followed by HPLC. After 8 h, the enzyme
was filtered off and washed with toluene (10 mL). The
organic layer was washed with 2 M HCl (2 · 25 mL) and
the combined acid was then washed with toluene
(10 mL). The pH of the aqueous layer was then adjusted
to 12 with 10 M NaOH and then extracted with TBME
(2 · 50 mL). The TBME was dried over MgSO4 and
evaporated to give (S)-1-methyltetrahydroisoquinoline
as a colourless oil (2.3 g, 46%, 99.65 ee). 1H NMR
(CDCl3): d 1.46 (d, 3H, J ¼ 6:8 Hz), 1.9 (br s, 1H), 2.73
(dt, 1H, J ¼ 16:3, 4.8 Hz), 2.87 (m, 1H), 3.02 (m 1H),
3.26 (dt, 1H, J ¼ 12:8, 5.0 Hz), 4.10 (q, 1H, J ¼ 6:8 Hz),
7.10 (m, 4H); MS MHþ 148.3 (100), 138.1 (20). The
toluene layer was stirred with 2 M NaOH (25 mL), then
dried over MgSO4 and evaporated to give carbamate 22
as a colourless oil (3.7 g, 47%, 98.4% ee). 1H NMR
(CDCl3): d 1.47 (d, 3H, J ¼ 6:8 Hz), 2.76 (dt, 1H,
J ¼ 16:1, 3.8 Hz), 2.94 (br s, 1H), 3.29 (br m, 1H), 4.16
(br m, 1H), 4.64 (dt, 2H, J ¼ 5:5, 1.5 Hz), 5.22 (dq, 2H,
J ¼ 10:5, 1.5 Hz), 5.33 (dq, J ¼ 17:2, 1.5 Hz), 5.97 (m,
1H), 7.15 (m, 4H); MS MHþ 232.1 (95), 188.2 (100),
145.1 (75).
3. Conclusions
Substituted phenyl allylcarbonates can be used to
increase the rate of acylation of 1-methytetrahydroiso-
quinoline with lipases. It is anticipated that these phenyl
allylcarbonates could be useful in other enzymatic
resolutions where the reactivity and selectivity can be
altered for a particular substrate by altering the substi-
tution on the phenol.
4. Experimental
4.1. General methods
Racemic 1-methyltetrahydroisoquinoline was obtained
from Yuhan Corporation. All other chemicals were
obtained from commercial sources and used without
further purification. NMR spectra were recorded with a
Bruker 400 MHz spectrometer. HPLC analyses were
performed on a Beckman Coulter 126/166 liquid chro-
matograph using a Phenomenex Aqua 150 · 4.6 mm 5 l
C18 column. The eluents used were 0.1% methanesulfo-
nic acid in water and 0.1% methanesulfonic acid in
acetonitrile, at 15–90% organic over 15 min then holding
at 90% organic for 3 min, with solvent flow at 1 mL/min
and UV detector at 210 nm. Chiral HPLC analysis was
performed using a Chiralcel-OD column, isocratic
analysis with 3% hexane in methanol as eluent, 1.5 mL/
min solvent flow and UV detector at 220 nm. MS anal-
yses were performed on a Waters Micromass ZQ.
References and notes
4.2. Screening procedure
1. Lee, J. W.; Chae, J. S.; Kim, C. S.; Kim, J. K.; Lim, D. S.;
Shon, M. K.; Choi, Y. S.; Lee, S. H. Patent WO9605177,
1996.
2. Patel, R. N. Enzyme Microb. Technol. 2002, 31, 804–826.
3. Gotor, V. Org. Proc. Res. Dev. 2002, 6, 420–426.
4. Straathof, A. J. J.; Panke, S.; Schmid, A. Curr. Opin.
Biotechnol. 2002, 13, 548–556.
1-Methyltetrahydroisoquinoline (115 mg) was dissolved
in diisopropyl ether (30 mL). One millilitre of this solu-
tion was added to a series of vials in a ChiroKitTM-TE
screening kit. Ethyl acetate (100 lL) was added to each
vial. The kit was shaken in an orbital shaker at 30 ꢁC for
48 h. A sample was taken from each vial to determine
whether any reaction had taken place.
5. van Rantwijk, F.; Sheldon, R. A. Tetrahedron 2004, 60,
501–519.
6. Morgan, B.; Zaks, A.; Dodds, D. R.; Liu, J.; Jain, R.;
Megati, S.; Njoroge, F. G.; Girijavallabhan, V. M. J. Org.
Chem. 2000, 65, 5451–5459.
7. Chiou, T.-W.; Chang, C.-C.; Lai, C.-T.; Tai, D.-F. Bioorg.
Med. Chem. Lett. 1997, 7, 433–436.
4.3. General procedure for the synthesis of carbonates 12–
21
8. Orsat, B.; Alper, P. B.; Moree, W.; Mak, C.-P.; Wond,
C.-H. J. Am. Chem. Soc. 1996, 118, 712–713.
9. Chen, S.-T.; Chen, S.-Y.; Kao, C.-L.; Wang, K.-T. Bioorg.
Med. Chem. Lett. 1994, 4, 443–448.
The phenol (50 mmol) and tetra-n-butylammonium
chloride hydrate (100 mg, 0.35 mmol) were dissolved in
dichloromethane (40 mL) and stirred with 4 M NaOH
(20 mL) at 0–5 ꢁC. Allyl chloroformate (6 mL,
56.5 mmol) was added slowly. After 1 h, the two layers
were separated and the organic layer washed with 2 M
ꢀ
10. Herradon, B.; Valverde, S. Synlett 1995, 599–602.
11. Gutman, A. L.; Meyer, E.; Yue, X.; Abell, C. Tetrahedron
Lett. 1992, 33, 3943–3946.